IRIDEX (NASDAQ:IRIX) Coverage Initiated by Analysts at StockNews.com

StockNews.com started coverage on shares of IRIDEX (NASDAQ:IRIX) in a report published on Monday morning. The brokerage issued a hold rating on the medical equipment provider’s stock.

IRIDEX Trading Down 5.3 %

Shares of NASDAQ IRIX opened at $1.07 on Monday. The company’s fifty day moving average is $1.52 and its 200-day moving average is $1.65. The stock has a market cap of $17.80 million, a price-to-earnings ratio of -1.60 and a beta of 0.94. IRIDEX has a twelve month low of $0.96 and a twelve month high of $3.65. The company has a quick ratio of 0.85, a current ratio of 1.54 and a debt-to-equity ratio of 0.55.

IRIDEX Company Profile

IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments.